dc.relation.reference | Albert, M.L., Sauter, B., and Bhardwaj, N. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89.
Aleman, M., de la Barrera, S., Schierloh, P., Yokobori, N., Baldini, M., Musella, R., Abbate, E., and Sasiain, M. (2007). Spontaneous or Mycobacterium tuberculosis-induced apoptotic neutrophils exert opposite effects on the dendritic cell-mediated immune response. Eur. J. Immunol. 37, 1524-1537.
Allendorfer, R., Brunner, G.D., and Deepe, G.S., Jr. (1999). Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162, 7389-7396.
Arrode, G., Boccaccio, C., Lule, J., Allart, S., Moinard, N., Abastado, J.P., Alam, A., and Davrinche, C. (2000). Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J. Virol. 74, 10018-10024.
Barry, M., and Bleackley, R.C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2, 401-409.
Batanghari JW, Goldman WE. (1994). Calcium dependence and binding in cultures of Histoplasma capsulatum. Infect Immun. 65, 5257-5261.
Bertholet, S., Goldszmid, R., Morrot, A., Debrabant, A., Afrin, F., Collazo-Custodio, C., Houde, M., Desjardins, M., Sher, A., and Sacks, D. (2006). Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J. Immunol. 177, 3525-3533.
Bevan, M.J. (1976). Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288.
Bevan, M.J. (1995). Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182, 639-641.
Blachere, N.E., Darnell, R.B., and Albert, M.L. (2005). Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol. 3, e185.
Blass, S.L., Pure, E., and Hunter, C.A. (2001). A role for CD44 in the production of IFN-gamma and immunopathology during infection with Toxoplasma gondii. J. Immunol. 166, 5726-5732.
Brummer, E., Kurita, N., Yosihida, S., Nishimura, K., and Miyaji, M. (1991). Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J. Infect. Dis. 164, 158-162.
Carbone, F.R., and Bevan, M.J. (1990). Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171, 377-387.
Cain JA, Deepe GS. (1998). Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66, 1473-1481.
Cebrian, M., Yague, E., Rincon, M., Lopez-Botet, M., de Landazuri, M.O., and Sanchez-Madrid, F. (1988). Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168, 1621-1637.
Deepe, G.S., Jr. (1994). Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152, 3491-3500.
DeGrendele, H.C., Estess, P., and Siegelman, M.H. (1997). Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675.
Fussenegger M. and Bailey JE. (1998) Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol Prog. 14, 807-833.
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P., and Amigorena, S. (2003). ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402.
Heninger E, Hogan LH, Karman J, Macvilay S, Hill B, Woods JP, Sandor M. (2006). Characterization of the Histoplasma capsulatum-induced granuloma. J Immunol. 177, 3303-1313.
Janeway, C.A., Jr. (1989). The priming of helper T cells. Semin. Immunol. 1, 13-20.
Janssen, E., Tabeta, K., Barnes, M.J., Rutschmann, S., McBride, S., Bahjat, K.S., Schoenberger, S.P., Theofilopoulos, A.N., Beutler, B., and Hoebe, K. (2006). Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 24, 787-799.
Kalies, K.U., Allan, S., Sergeyenko, T., Kroger, H., and Romisch, K. (2005). The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. Embo. J. 24, 2284-2293.
Koszinowski UH, Reddehase MJ, Jonjic S. (1991). The role of CD4 and CD8 T cells in viral infections. Curr. Opin. Immunol. 3, 471-475.
Kugler, S., Schurtz Sebghati, T., Groppe Eissenberg, L., and Goldman, W.E. (2000). Phenotypic variation and intracellular parasitism by histoplasma Capsulatum. Proc. Natl. Acad. Sci. U S A 97, 8794-8798.
Lane, T.E., Otero, G.C., Wu-Hsieh, B.A., and Howard, D.H. (1994). Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun. 62, 1478-1479.
Lane, T.E., Wu-Hsieh, B.A., and Howard, D.H. (1991). Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 59, 2274-2278.
Liao, D.J. (2005). The scavenger cell hypothesis of apoptosis: apoptosis redefined as a process by which a cell in living tissue is destroyed by phagocytosis. Med. Hypotheses 65, 23-28.
Lin, J.S., and Wu-Hsieh, B.A. (2004). Functional T cells in primary immune response to histoplasmosis. Int. Immunol. 16, 1663-1673.
Lin, J.S., Yang, C.W., Wang, D.W., and Wu-Hsieh, B.A. (2005). Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J. Immunol. 174, 6282-6291.
Neijssen, J., Herberts, C., Drijfhout, J.W., Reits, E., Janssen, L., and Neefjes, J. (2005). Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434, 83-88.
Newman, S.L. (1999). Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 7, 67-71.
Newman, S.L., Gootee, L., and Gabay, J.E. (1993). Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J. Clin. Invest. 92, 624-631.
Rappleye, C.A., Eissenberg, L.G., and Goldman, W.E. (2007). capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc. Natl. Acad. Sci. U S A 104, 1366-1370.
Rappleye, C.A., Engle, J.T., and Goldman, W.E. (2004). RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol. Microbiol. 53, 153-165.
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999). Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189, 371-380.
Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M.P., Garancini, M.P., Manfredi, A.A., Rugarli, C., and Bellone, M. (1999). Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol. 163, 130-136.
Roohvand F, Aghasadeghi MR, Sadat SM, Budkowska A, Khabiri AR. (2007). HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses. Biochem Biophys Res Commun. 354(3), 641-649.
San-Blas G, Carbonell LM. (1974) Chemical and ultrastructural studies on the cell walls of the yeastlike and mycelial forms of Histoplasma farciminosum. J. Bacteriol. 119(2), 602-611.
Sa-Nunes, A., Medeiros, A.I., Sorgi, C.A., Soares, E.G., Maffei, C.M., Silva, C.L., and Faccioli, L.H. (2006). Gr-1(+) cells play an essential role in an experimental model of disseminated histoplasmosis. Microbes Infect. doi:10.1016/j.micinf 2006.10.007
Sancho, D., Gomez, M., Viedma, F., Esplugues, E., Gordon-Alonso, M., Garcia-Lopez, M.A., de la Fuente, H., Martinez, A.C., Lauzurica, P., and Sanchez-Madrid, F. (2003). CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J. Clin. Invest. 112, 872-882.
Santis, A.G., Campanero, M.R., Alonso, J.L., Tugores, A., Alonso, M.A., Yague, E., Pivel, J.P., and Sanchez-Madrid, F. (1992). Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 22, 1253-1259.
Savill, J., Fadok, V., Henson, P., and Haslett, C. (1993). Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14, 131-136.
Schaible, U.E., Winau, F., Sieling, P.A., Fischer, K., Collins, H.L., Hagens, K., Modlin, R.L., Brinkmann, V., and Kaufmann, S.H. (2003). Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 9, 1039-1046.
Schnorrer, P., Behrens, G.M., Wilson, N.S., Pooley, J.L., Smith, C.M., El-Sukkari, D., Davey, G., Kupresanin, F., Li, M., Maraskovsky, E., et al. (2006). The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. U S A 103, 10729-10734.
Shen, L., and Rock, K.L. (2006). Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol. 18, 85-91.
Shen, L., Sigal, L.J., Boes, M., and Rock, K.L. (2004). Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21, 155-165.
Sigal, L.J., Crotty, S., Andino, R., and Rock, K.L. (1999). Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80.
Skoberne, M., Beignon, A.S., Larsson, M., and Bhardwaj, N. (2005). Apoptotic cells at the crossroads of tolerance and immunity. Curr. Top. Microbiol. Immunol. 289, 259-292.
Subklewe, M., Paludan, C., Tsang, M.L., Mahnke, K., Steinman, R.M., and Munz, C. (2001). Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J. Exp. Med. 193, 405-411.
Suto, R., and Srivastava, P.K. (1995). A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588.
Taylor, P.R., Tsoni, S.V., Willment, J.A., Dennehy, K.M., Rosas, M., Findon, H., Haynes, K., Steele, C., Botto, M., Gordon, S., et al. (2007). Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8, 31-38.
Wang, J., Santosuosso, M., Ngai, P., Zganiacz, A., and Xing, Z. (2004). Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 173, 4590-4597.
Winau, F., Kaufmann, S.H., and Schaible, U.E. (2004). Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell. Microbiol. 6, 599-607.
Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S.L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S.H., and Schaible, U.E. (2006). Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24, 105-117.
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303.
Wu-Hsieh BA, Howard DH. (1987). Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect. Immun. 55, 1014-1016.
Wu-Hsieh B, Zlotnik A, Howard DH. (1984). T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum. Infect. Immun. 43, 380-385.
Wuthrich, M., Filutowicz, H.I., Warner, T., Deepe, G.S., Jr., and Klein, B.S. (2003). Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197, 1405-1416.
Yrlid, U., and Wick, M.J. (2000). Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191, 613-624.
Ziegler SF, Ramsdell F, Alderson MR. (1994). The activation antigen CD69. Stem Cells. 12, 456-65. | en |